Literature DB >> 30825433

Micro-RNAs in inflammatory arthritis: From physiopathology to diagnosis, prognosis and therapeutic opportunities.

Aurélie Najm1, Frédéric Blanchard2, Benoit Le Goff3.   

Abstract

Micro-RNAs are an area of research exponentially expanding over the past years. These small sequences of 20-22 nucleotides have a strong role as post-transcriptional regulators of gene expression. Inflammatory arthritis pathophysiology involves various key players from innate to adaptive immunity, as well as various signalling pathways of inflammation. In this review, we discuss how micro-RNAs are involved in rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and juvenile inflammatory arthritis, from pre-clinical phases to established diseases. We describe mi-RNAs key roles in fibroblast like synoviocytes migration, proliferation, apoptosis and cytokine production, in macrophages polarization, as well as in B cells and T cell proliferation and differentiation, with a special emphasis on Treg/Th17 imbalance. We finally discuss the application of these findings in pre-clinical models and highlight opportunities and limits of a therapeutic approach using mi-RNAs agonists or antagonists.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Arthritis; Fibroblasts like synoviocytes; Inflammation; Mi-RNA; Micro-RNA; Rheumatoid arthritis

Mesh:

Substances:

Year:  2019        PMID: 30825433     DOI: 10.1016/j.bcp.2019.02.031

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  4 in total

1.  Clinical Significance of Peripheral Blood Th1 and Th17 Cell Content and Serum IL-35 and IL-17 Expression in Patients with Ankylosing Spondylitis.

Authors:  Haitao Tan; Shan Huang; Tingrui Wang
Journal:  Evid Based Complement Alternat Med       Date:  2022-05-18       Impact factor: 2.650

2.  Serum miRNA Signature in Rheumatoid Arthritis and "At-Risk Individuals".

Authors:  Clare C Cunningham; Sarah Wade; Achilleas Floudas; Carl Orr; Trudy McGarry; Siobhan Wade; Sian Cregan; Ursula Fearon; Douglas J Veale
Journal:  Front Immunol       Date:  2021-03-03       Impact factor: 7.561

Review 3.  miRNAs as Biomarkers and Possible Therapeutic Strategies in Rheumatoid Arthritis.

Authors:  Tomasz Kmiołek; Agnieszka Paradowska-Gorycka
Journal:  Cells       Date:  2022-01-28       Impact factor: 6.600

4.  Prophylactic administration of miR-451 inhibitor decreases osteoarthritis severity in rats.

Authors:  Kayla M Scott; D Joshua Cohen; Dane W Nielson; Gloria Kim; Lucas C Olson; Michael J McClure; Mark W Grinstaff; Barbara D Boyan; Zvi Schwartz
Journal:  Sci Rep       Date:  2022-09-27       Impact factor: 4.996

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.